Cogent Biosciences, Inc.
COGT
$34.29
-$0.24-0.70%
NASDAQ
| 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -3.82% | 130.44% | 64.34% | -3.18% | -14.43% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 19.13% | 50.93% | -11.26% | -0.87% | -23.12% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -3.58% | 129.17% | 62.14% | -3.11% | -14.70% |
|
|
|||||
| Total Current Assets | -3.58% | 129.17% | 62.14% | -3.11% | -14.70% |
| Net Property, Plant & Equipment | -2.92% | -1.38% | -4.34% | -4.24% | -1.93% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -36.62% | -22.95% | -0.78% | 0.00% | 0.00% |
| Total Assets | -3.69% | 120.13% | 54.99% | -3.16% | -13.45% |
|
|
|||||
| Total Accounts Payable | 44.61% | -40.71% | -3.58% | 17.46% | 17.82% |
| Total Accrued Expenses | -11.16% | 6.78% | 11.22% | 17.53% | -20.81% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -10.60% | -9.32% | 2.90% | 2.92% | 2.94% |
| Total Finance Division Other Current Liabilities | -72.63% | 424.90% | 0.94% | 163.02% | 29.76% |
| Total Other Current Liabilities | -72.63% | 424.90% | 0.94% | 163.02% | 29.76% |
| Total Current Liabilities | -9.34% | 2.74% | 6.55% | 18.46% | -11.47% |
|
|
|||||
| Total Current Liabilities | -9.34% | 2.74% | 6.55% | 18.46% | -11.47% |
| Long-Term Debt | 0.12% | 403.72% | 0.68% | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.80% | -1.70% | -2.98% | -2.77% | -2.65% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 87.88% | -98.61% | 0.47% | 47,080.00% | -- |
| Total Liabilities | -1.97% | 143.98% | 3.08% | 84.84% | -9.51% |
|
|
|||||
| Common Stock & APIC | 5.42% | 35.52% | 21.69% | 0.96% | 3.72% |
| Retained Earnings | -8.19% | -9.44% | -8.05% | -7.89% | -8.38% |
| Treasury Stock & Other | -216.90% | 70.67% | 1,500.00% | -92.07% | -63.31% |
| Total Common Equity | -0.74% | 181.15% | 312.87% | -57.48% | -23.93% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -27.56% | -17.16% | 0.00% | -0.23% | -2.20% |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -27.56% | -17.16% | 0.00% | -0.23% | -2.20% |
|
|
|||||
| Total Common Equity | -0.74% | 181.15% | 312.87% | -57.48% | -23.93% |
| Total Preferred Equity | -27.56% | -17.16% | 0.00% | -0.23% | -2.20% |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -4.51% | 110.40% | 95.09% | -29.21% | -14.55% |
|
|
|||||